Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

UNCY Unicycive Therapeutics, Inc.

休市中 07-24 16:00:00 EDT

5.40

-0.06

-1.10%

盘后5.32

-0.08-1.48%

19:45 EDT

最高5.59	最低5.31	成交量49.77万
今开5.50	昨收5.46	日振幅5.22%
总市值1.48亿	流通市值1.35亿	总股本2,739万
成交额267.86万	换手率1.99%	流通股本2,497万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":5.4,"timestamp":1784923200000,"preClose":5.46,"halted":0,"volume":497709,"hourTrading":{"tag":"盘后","latestPrice":5.32,"preClose":5.4,"latestTime":"19:45 EDT","volume":7825,"amount":42232.196,"timestamp":1784936701605,"change":-0.08,"changeRate":-0.014815,"amplitude":0.014815},"delay":0,"changeRate":-0.010989010989010917,"floatShares":24973600,"shares":27393027,"eps":-2.108803,"marketStatus":"休市中","change":-0.06,"latestTime":"07-24 16:00:00 EDT","open":5.5,"high":5.59,"low":5.305,"amount":2678590.702269,"amplitude":0.052198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.108803,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":5.46,"preHourTrading":{"tag":"盘前","latestPrice":5.3892,"preClose":5.46,"latestTime":"09:15 EDT","volume":2359,"amount":13164.863279399999,"timestamp":1784898919830,"change":-0.0708,"changeRate":-0.012967,"amplitude":0.06044},"postHourTrading":{"tag":"盘后","latestPrice":5.32,"preClose":5.4,"latestTime":"19:45 EDT","volume":7825,"amount":42232.196,"timestamp":1784936701605,"change":-0.08,"changeRate":-0.014815,"amplitude":0.014815},"volumeRatio":0.5685493378579597,"impliedVol":0.1822,"impliedVolPercentile":0.0279},"requestUrl":"/m/hq/s/UNCY","defaultTab":"news","newsList":[{"id":"1160150684","title":"Unicycive Therapeutics收到FDA就重报的Oxylanthanum Carbonate新药申请发出的完整回复函","url":"https://stock-news.laohu8.com/highlight/detail?id=1160150684","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160150684?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:23","pubTimestamp":1783322581,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics Inc. 宣布，其已收到美国食品药品监督管理局（FDA）就重报的Oxylanthanum Carbonate（OLC）新药申请（NDA）发出的完整回复函。\nFDA在函件中未对OLC的临床疗效或安全性数据提出疑虑，也未要求公司提供额外的数据。然而，FDA指出，其尚未对重报NDA所涉及的第三方生产商进行检查。此次完整回复函是基于FDA在2025年6月识别出的第三方生产缺陷。\nUnicycive Therapeutics表示，公司对OLC的疗效和安全性依然充满信心，并乐观地认为将能够迅速重新提交NDA申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647426551","title":"Unicycive Therapeutics股价下跌45.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647426551","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647426551?lang=zh_cn&edition=full","pubTime":"2026-06-30 21:32","pubTimestamp":1782826373,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics股价下跌45.8%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606303788649482.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303788649482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4007","UNCY","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167377069","title":"Unicycive Therapeutics 肾病新药遭FDA拒绝批准，盘前股价暴跌36.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167377069","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167377069?lang=zh_cn&edition=full","pubTime":"2026-06-30 19:23","pubTimestamp":1782818608,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）决定不批准Unicycive Therapeutics, Inc.的肾病治疗药物，这一突如其来的消息导致该公司股价在盘前交易时段重挫36.9%。监管机构的否决对这家专注于肾脏疾病疗法的生物技术公司构成了重大打击。\n市场对此反应剧烈，股价的急剧下跌凸显了投资者对该药物获批前景的高度期待，以及监管决定对生物科技公司估值的巨大影响。此次挫折不仅影响了Unicycive的短期市场表现，也可能对其未来的研发策略和资金筹措带来挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194955967","title":"Unicycive Therapeutics 对 OLC 疗效与安全性保持信心；预计将能迅速重新提交新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1194955967","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194955967?lang=zh_cn&edition=full","pubTime":"2026-06-30 19:09","pubTimestamp":1782817754,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics 重申，其对 OLC 的疗效与安全性保持充分信心。公司管理层表示，他们乐观地认为，将能够迅速完成必要的准备工作，并重新向监管机构提交新药申请（NDA）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162475730","title":"Unicycive Therapeutics收到FDA关于奥兰酸镧（OLC）新药申请重新提交的完整回复函","url":"https://stock-news.laohu8.com/highlight/detail?id=1162475730","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162475730?lang=zh_cn&edition=full","pubTime":"2026-06-30 19:07","pubTimestamp":1782817679,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics公司宣布，已收到美国食品药品监督管理局（FDA）就其重新提交的奥兰酸镧（OLC）新药申请（NDA）发出的完整回复函。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187764821","title":"Unicycive Therapeutics——FDA尚未对重新提交NDA所涉第三方生产商进行现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=1187764821","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187764821?lang=zh_cn&edition=full","pubTime":"2026-06-30 19:07","pubTimestamp":1782817633,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics公司宣布，美国食品药品监督管理局（FDA）目前尚未对其新药申请（NDA）重新提交所依赖的第三方生产供应商进行现场检查。这一进展表明，该药物审批流程中的关键监管环节仍在进行中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103147836","title":"Unicycive Therapeutics提交销售协议招股书，拟发售最多5000万美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103147836","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103147836?lang=zh_cn&edition=full","pubTime":"2026-06-06 04:18","pubTimestamp":1780690701,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics, Inc. 已向美国证券交易委员会提交了一份销售协议招股书，计划发售价值最高达5000万美元的普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109670417","title":"更新：Unicycive Therapeutics宣布FDA受理碳酸氧镧（OLC）新药申请重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1109670417","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109670417?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:16","pubTimestamp":1769696171,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics, Inc.披露，美国食品药品监督管理局（FDA）已正式接受其针对碳酸氧镧（OLC）的新药申请（NDA）重新提交。该进展标志着公司在推进该药物治疗方案方面迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508689142","title":"Unicycive Therapeutics, Inc.盘中异动 早盘股价大跌5.18%报0.582美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508689142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508689142?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:14","pubTimestamp":1738595693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时14分，Unicycive Therapeutics, Inc.股票出现波动，股价急速跳水5.18%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为515.94%、401.47%、278.93%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为136.56%、75.23%、50.76%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231453a2381301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231453a2381301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507808146","title":"HC Wainwright & Co.：重申Unicycive Therapeutics(UNCY.US)评级，由买入调整至买入评级, 目标价由4.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507808146","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507808146?lang=zh_cn&edition=full","pubTime":"2025-01-29 20:20","pubTimestamp":1738153253,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Unicycive Therapeutics(UNCY.US)评级，由买入调整至买入评级, 目标价由4.00美元调整至4.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29202047897460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491371490","title":"Unicycive Therapeutics, Inc.盘中异动 早盘快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491371490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491371490?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:52","pubTimestamp":1734101544,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时52分，Unicycive Therapeutics, Inc.股票出现异动，股价快速跳水5.41%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225224a1ec3c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225224a1ec3c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488281829","title":"Unicycive Therapeutics, Inc.盘中异动 快速跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488281829","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488281829?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:44","pubTimestamp":1733244264,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时44分，Unicycive Therapeutics, Inc.股票出现波动，股价快速跳水5.22%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204004424abf33817&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204004424abf33817&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2487556838","title":"Unicycive Therapeutics, Inc.盘中异动 快速上涨5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487556838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487556838?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:43","pubTimestamp":1732891428,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时43分，Unicycive Therapeutics, Inc.股票出现波动，股价大幅上涨5.96%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224348971aa72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224348971aa72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486466838","title":"Unicycive Therapeutics, Inc.盘中异动 下午盘大幅上涨5.41%报0.583美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486466838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486466838?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:26","pubTimestamp":1732649199,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时26分，Unicycive Therapeutics, Inc.股票出现异动，股价快速上涨5.41%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体，在晚期临床前开发中已获得物质成分专利保护，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127032639971a8b3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127032639971a8b3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483809095","title":"Unicycive Therapeutics, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809095?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594685,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Unicycive Therapeutics, Inc.股票出现波动，股价快速下跌5.21%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1403.84%、19.59%、11.31%，振幅较大的相关个股有Pulmatrix, Inc.、Cargo Therapeutics, Inc.、Heron Therapeutics, Inc.，振幅分别为9.83%、8.67%、8.60%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312598e42a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422312598e42a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2476498120","title":"Unicycive Therapeutics, Inc.盘中异动 早盘大幅拉升5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476498120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476498120?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:41","pubTimestamp":1729172479,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时41分，Unicycive Therapeutics, Inc.股票出现波动，股价急速上涨5.66%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.涨幅较大，Notable Labs, Ltd.、Molecular Templates, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为317.36%、225.32%、146.29%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、Tevogen Bio Holdings Inc.，振幅分别为56.36%、37.28%、28.85%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家生物技术公司，致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214120ab6ad87a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017214120ab6ad87a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UNCY","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.3156},{"period":"3month","weight":-0.2593},{"period":"6month","weight":-0.2197},{"period":"1year","weight":0.1134},{"period":"ytd","weight":-0.0641}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司是一家生物技术公司，致力于开发针对某些医疗条件的治疗方法。目前，该公司的两个项目专注于肾脏疾病。随着公司的发展和团队的建立，公司打算专注于识别肾脏疾病内外的医疗状况。该公司目前的开发项目专注于两种新疗法：碳酸氧氰，用于治疗透析慢性肾病患者的高磷血症，以及UNI494，用于治疗急性肾损伤（AKI）。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.078139},{"month":2,"riseRate":0.6,"avgChangeRate":0.088088},{"month":3,"riseRate":0.4,"avgChangeRate":0.59683},{"month":4,"riseRate":0.4,"avgChangeRate":-0.11937},{"month":5,"riseRate":0.4,"avgChangeRate":-0.060546},{"month":6,"riseRate":0,"avgChangeRate":-0.217882},{"month":7,"riseRate":0.2,"avgChangeRate":-0.05217},{"month":8,"riseRate":0.2,"avgChangeRate":-0.122604},{"month":9,"riseRate":0.6,"avgChangeRate":0.038818},{"month":10,"riseRate":0.8,"avgChangeRate":0.050976},{"month":11,"riseRate":0.6,"avgChangeRate":0.060673},{"month":12,"riseRate":0.4,"avgChangeRate":0.09852}],"exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}